Isto Biologics (Formerly Arteriocyte) Revenue and Competitors
Estimated Revenue & Valuation
- Isto Biologics (Formerly Arteriocyte)'s estimated annual revenue is currently $40.7M per year.
- Isto Biologics (Formerly Arteriocyte)'s estimated revenue per employee is $251,000
Employee Data
- Isto Biologics (Formerly Arteriocyte) has 162 Employees.
- Isto Biologics (Formerly Arteriocyte) grew their employee count by 8% last year.
Isto Biologics (Formerly Arteriocyte)'s People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP Operations | Reveal Email/Phone |
4 | VP, Regulatory & Quality Affairs | Reveal Email/Phone |
5 | Controller | Reveal Email/Phone |
6 | General Counsel | Reveal Email/Phone |
7 | VP Sales and Marketing | Reveal Email/Phone |
8 | VP, Human Resources | Reveal Email/Phone |
9 | Area VP Sales, East | Reveal Email/Phone |
10 | Area VP Sales | Reveal Email/Phone |
Isto Biologics (Formerly Arteriocyte) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11M | 44 | 13% | N/A | N/A |
#2 | $11M | 44 | 29% | N/A | N/A |
#3 | $4.3M | 17 | 0% | N/A | N/A |
#4 | $3.8M | 15 | -29% | N/A | N/A |
#5 | $5630M | 9122 | -11% | $450M | N/A |
#6 | $4.3M | 17 | 0% | N/A | N/A |
#7 | $4M | 16 | -72% | $23.5M | N/A |
#8 | $44.4M | 177 | 9% | N/A | N/A |
#9 | $45.7M | 182 | 0% | N/A | N/A |
#10 | $15M | 79 | 8% | $105.2M | N/A |
What Is Isto Biologics (Formerly Arteriocyte)?
Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The company's best-in-class product offerings include Arteriocyte's market-leading Magellan® Autologous Platelet Separator and Isto's bone-growth and cell-therapy products including InQu® Bone Graft Extender & Substitute; Influx®, a natural bone-graft material; and CellPoint®, a concentrated bone marrow aspirate system.
keywords:N/AN/A
Total Funding
162
Number of Employees
$40.7M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 163 | 4% | N/A |
#2 | $34.4M | 222 | 0% | N/A |
#3 | $61.9M | 330 | 6% | N/A |
#4 | $151.9M | 377 | 21% | N/A |
#5 | $71.5M | 402 | -1% | N/A |